Prescription drug prior authorization.
(a)#
The secretary shall exercise his or her authority under s. 15.04 (1) (c) to create a prescription drug prior authorization committee to advise the department on issues related to prior authorization decisions made concerning prescription drugs on behalf of medical assistance recipients. The secretary shall appoint as members at least all of the following: 1. Two physicians, as defined in s. 448.01 (5), who are currently in practice. 2. Two pharmacists, as defined in s. 450.01 (15). 3. One advocate for recipients of medical assistance who has sufficient medical background, as determined by the department, to evaluate a prescription drug’s clinical effectiveness.
(a)(1)#
Two physicians, as defined in s. 448.01 (5), who are currently in practice.
(a)(2)#
Two pharmacists, as defined in s. 450.01 (15).
(a)(3)#
One advocate for recipients of medical assistance who has sufficient medical background, as determined by the department, to evaluate a prescription drug’s clinical effectiveness.
(b)#
The prescription drug prior authorization committee shall accept information or commentary from representatives of the pharmaceutical manufacturing industry in the committee’s review of prior authorization policies.